Correlation Between Catalyst Pharmaceuticals and LENSAR
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and LENSAR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and LENSAR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and LENSAR Inc, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and LENSAR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of LENSAR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and LENSAR.
Diversification Opportunities for Catalyst Pharmaceuticals and LENSAR
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Catalyst and LENSAR is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and LENSAR Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LENSAR Inc and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with LENSAR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LENSAR Inc has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and LENSAR go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and LENSAR
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 2.8 times less return on investment than LENSAR. But when comparing it to its historical volatility, Catalyst Pharmaceuticals is 1.97 times less risky than LENSAR. It trades about 0.08 of its potential returns per unit of risk. LENSAR Inc is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 226.00 in LENSAR Inc on September 3, 2024 and sell it today you would earn a total of 529.00 from holding LENSAR Inc or generate 234.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. LENSAR Inc
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| LENSAR Inc |
Catalyst Pharmaceuticals and LENSAR Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and LENSAR
The main advantage of trading using opposite Catalyst Pharmaceuticals and LENSAR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, LENSAR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENSAR will offset losses from the drop in LENSAR's long position.| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |